Esther Biemans
Esther Biemans is a Senior Scientist and Project Manager at Ardena. She brings extensive experience in large molecule analysis and has specialized in developing and validating PK, PD, and ADA assays for a wide range of drug development projects over the past 15 years.
Since moving into the CRO industry in 2010, Esther has worked as a senior scientist and project manager, building extensive expertise in large molecule bioanalysis.
Esther obtained her PhD in Biochemistry from the University of Groningen in 2006, focusing on immunology and enzymology. She subsequently completed postdoctoral research at the University of British Columbia in Vancouver before transitioning into the CRO industry.
Henri Meijering
Henri Meijering is Associate Director Operations at Ardena Bioanalysis. He brings expertise in drug development and pharmacokinetics, with a strong focus on bioanalytical chemistry and mass spectrometric techniques.
Since joining Ardena in 2012, Henri has held several roles across the organization, including Project Manager, Team Lead Project Management, and Business Support Manager. In his current role, he leads teams specializing in small and large molecule LC-MS/MS analysis and oversees laboratory operations and project management activities.
Henri received his master’s degree in Pharmaceutical Sciences from Vrije Universiteit Amsterdam, specializing in bioanalytical chemistry and mass spectrometric techniques. With more than two decades of experience, he is dedicated to advancing scientific excellence and fostering collaboration within the bioanalytical field.
Gunnar Flik, PhD
Gunnar Flik joined Ardena in 2024 as Division Head of Bioanalytical Services. With over 20 years of experience in drug discovery within biotech and CRO environments, Gunnar brings a wealth of strategic vision and entrepreneurial expertise to his role. He is dedicated to developing comprehensive short- and long-term strategic plans aimed at optimizing efficiency, fostering growth, and enhancing profitability within Ardena’s Bioanalysis division.
Prior to joining Ardena, Gunnar served as owner and Managing Director of operations EU of Brains On-Line which was later acquired by Charles River Laboratories (CRL). He led the successful and seamless integration of Brains On-Line into CRL. Gunnar played a pivotal role in the seamless integration of Brains On-Line into CRL, where he subsequently served as Site Director and contributed to strategic initiatives within the Discovery Business Unit, advising on partnerships and M&A activities.
Gunnar holds a PhD in Neuropharmacology.